The 6 analysts offering 12-month price forecasts for Surgalign Holdings Inc have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 2.50. The median estimate represents a +113.52% increase from the last price of 1.41.
The current consensus among 6 polled investment analysts is to Buy stock in Surgalign Holdings Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.09
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.